Universal Vaccines
- All
- News
- Videos
-
Universal Vaccines Could Reshape How We Fight Future Outbreaks
Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.
-
Mpox Vaccines Prequalified by WHO, Shipped to Africa to Contain the Outbreak
The arrival of mpox vaccines in Africa, particularly the Jynneos vaccine from Bavarian Nordic, aims to combat a significant resurgence of the virus, especially in the Democratic Republic of the Congo. The World Health Organization has reported approximately 6,000 confirmed cases across 15 African nations, with concerns about transmission dynamics, ...
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
A New All-In-One Vaccine May Prove Effective Against All Coronaviruses
A team of scientists from the world's leading universities have developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are yet to emerge.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
This Man Had Covid-19 For Almost 2 Years, So Long It Mutated Into A New Variant
Despite being vaccinated, his compromised immune system couldn't fully fend off the virus, leading to severe complications.
-
IIT Guwahati Develops India's 1st Recombinant Vaccine For Swine Fever
The Indian Institute of Technology-Guwahati has successfully transferred the technology to produce the country's first recombinant vaccine against classical swine fever to the biotech firm Bio-Med.
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
-
Universal Vaccines Could Reshape How We Fight Future Outbreaks
Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.
-
Mpox Vaccines Prequalified by WHO, Shipped to Africa to Contain the Outbreak
The arrival of mpox vaccines in Africa, particularly the Jynneos vaccine from Bavarian Nordic, aims to combat a significant resurgence of the virus, especially in the Democratic Republic of the Congo. The World Health Organization has reported approximately 6,000 confirmed cases across 15 African nations, with concerns about transmission dynamics, ...
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
A New All-In-One Vaccine May Prove Effective Against All Coronaviruses
A team of scientists from the world's leading universities have developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are yet to emerge.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
This Man Had Covid-19 For Almost 2 Years, So Long It Mutated Into A New Variant
Despite being vaccinated, his compromised immune system couldn't fully fend off the virus, leading to severe complications.
-
IIT Guwahati Develops India's 1st Recombinant Vaccine For Swine Fever
The Indian Institute of Technology-Guwahati has successfully transferred the technology to produce the country's first recombinant vaccine against classical swine fever to the biotech firm Bio-Med.
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
Bharat Biotech, Sydney University Announce Pact To Advance Vaccine Research
Bharat Biotech and the University of Sydney Infectious Diseases Institute Tuesday announced a memorandum of understanding between them to advance vaccine research initiatives, strengthen academic-industry partnerships and
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
